Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leukemia × Razoxane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Cardiotoxicity 4 Lymphoma 3 Sarcoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 PRETEXT I Hepatoblastoma 1 Neuroblastoma 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Ganglioneuroblastoma 1 Burkitt Lymphoma 1

Interventions

Cytarabine 61 Cyclophosphamide 41 Methotrexate 37 Etoposide 32 Daunorubicin 31 Vincristine 27 Mercaptopurine 24 Idarubicin 22 Dexamethasone 22 Radiotherapy 20 Thioguanine 18 Doxorubicin 18 Asparaginase 18 pegaspargase 15 Prednisone 15 Busulfan 15 Peripheral Blood Stem Cell Transplantation 14 Mitoxantrone 14 Imatinib Mesylate 14 Filgrastim 11 fludarabine phosphate 10 Leucovorin 9 nilotinib 8 Hydrocortisone 8 Cyclosporine 8 Prednisolone 7 Hydroxyurea 7 Epoetin Alfa 7 Tretinoin 6 Rituximab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01230983 2013-06-06

T-Cell #4

Children's Oncology Group

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡